Long-term follow-up of serum immunoglobulin levels in blinatumomab-treated patients with minimal residual disease-positive B-precursor acute lymphoblastic leukemia

被引：69
作者：
Zugmaier, G. [1 ]
Topp, M. S. [2 ,3 ]
Alekar, S. [4 ]
Viardot, A. [5 ]
Horst, H-A [6 ,7 ]
Neumann, S. [6 ,7 ]
Stelljes, M. [8 ]
Bargou, R. C. [3 ]
Goebeler, M. [3 ]
Wessiepe, D. [9 ]
Degenhard, E. [1 ]
Goekbuget, N. [10 ]
Klinger, M. [1 ]
机构：
[1] Amgen Res Munich GmbH, Munich, Germany
[2] Univ Klinikum Wurzburg, Med Klin & Poliklin 2, Wurzburg, Germany
[3] Univ Klinikum Wurzburg, Comprehens Canc Ctr Mainfranken, Wurzburg, Germany
[4] Amgen Inc, Thousand Oaks, CA 91320 USA
[5] Univ Ulm, Dept Med 3, D-89069 Ulm, Germany
[6] City Hosp, Dept Med 2, Kiel, Germany
[7] Univ Hosp Schleswig Holstein, Kiel, Germany
[8] Univ Munster, Bone Marrow Transplantat Ctr, D-48149 Munster, Germany
[9] Metronomia GmbH, Munich, Germany
[10] Goethe Univ Frankfurt, Ctr Internal Med, Frankfurt, Germany
来源：
BLOOD CANCER JOURNAL | 2014年 / 4卷
关键词：
STEM-CELL TRANSPLANTATION; ENGAGING ANTIBODY; FREE SURVIVAL; RITUXIMAB; LYMPHOMA; HYPOGAMMAGLOBULINEMIA; LINEAGE;
D O I：
10.1038/bcj.2014.64
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：e244 / e244
页数：4
相关论文
共 15 条
  • [1] Tumor regression in cancer patients by very low doses of a T cell-engaging antibody
    Bargou, Ralf
    Leo, Eugen
    Zugmaier, Gerhard
    Klinger, Matthias
    Goebeler, Mariele
    Knop, Stefan
    Noppeney, Richard
    Viardot, Andreas
    Hess, Georg
    Schuler, Martin
    Einsele, Hermann
    Brandl, Christian
    Wolf, Andreas
    Kirchinger, Petra
    Klappers, Petra
    Schmidt, Margit
    Riethmueller, Gert
    Reinhardt, Carsten
    Baeuerle, Patrick A.
    Kufer, Peter
    [J]. SCIENCE, 2008, 321 (5891) : 974 - 977
  • [2] B-cell targeted therapeutics in clinical development
    Blueml, Stephan
    McKeever, Kathleen
    Ettinger, Rachel
    Smolen, Josef
    Herbst, Ronald
    [J]. ARTHRITIS RESEARCH & THERAPY, 2013, 15
  • [3] Incidence of Hypogammaglobulinemia in Patients Receiving Rituximab and the Use of Intravenous Immunoglobulin for Recurrent Infections
    Casulo, Carla
    Maragulia, Jocelyn
    Zelenetz, Andrew D.
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2013, 13 (02) : 106 - 111
  • [4] Does rituximab aggravate pre-existing hypogammaglobulinaemia?
    Diwakar, Lavanya
    Gorrie, Sheryl
    Richter, Alex
    Chapman, Oliver
    Dhillon, Paul
    Al-Ghanmi, Fayza
    Noorani, Sadia
    Krishna, Mamidipudi T.
    Huissoon, Aarnoud
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 2010, 63 (03) : 275 - 277
  • [5] Dunleavy K, 2010, BLOOD, V116
  • [6] Severe hypogammaglobulinemia persisting for 6 years after treatment with rituximab combined chemotherapy due to arrest of B lymphocyte differentiation together with alteration of T lymphocyte homeostasis
    Irie, Erika
    Shirota, Yuko
    Suzuki, Chihiro
    Tajima, Yumi
    Ishizawa, Kenichi
    Kameoka, Junichi
    Harigae, Hideo
    Ishii, Tomonori
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2010, 91 (03) : 501 - 508
  • [7] Immunologic recovery following autologous stem-cell transplantation with pre- and posttransplantation rituximab for low-grade or mantle cell lymphoma
    Kasamon, Y. L.
    Jones, R. J.
    Brodsky, R. A.
    Fuchs, E. J.
    Matsui, W.
    Luznik, L.
    Powell, J. D.
    Blackford, A. L.
    Goodrich, A.
    Gocke, C. D.
    Abrams, R. A.
    Ambinder, R. F.
    Flinn, I. W.
    [J]. ANNALS OF ONCOLOGY, 2010, 21 (06) : 1203 - 1210
  • [8] Murphy K., 2011, Janeway's Immunobiology, V1
  • [9] Delayed redistribution of CD27, CD40 and CD80 positive B cells and the impaired in vitro immunoglobulin production in patients with non-Hodgkin lymphoma after rituximab treatment as an adjuvant to autologous stem cell transplantation
    Nishio, Mitsufumi
    Fujimoto, Katsuya
    Yamamoto, Satoshi
    Endo, Tomoyuki
    Sakai, Toshiya
    Obara, Masato
    Kumano, Kohki
    Yamaguchi, Keisuke
    Takeda, Yukari
    Goto, Hideki
    Sato, Norihiro
    Koizumi, Kazuki
    Mukai, Masaya
    Koike, Takao
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2007, 137 (04) : 349 - 354
  • [10] Long-term follow-up of hematologic relapse-free survival in a phase 2 study of blinatumomab in patients with MRD in B-lineage ALL
    Topp, Max S.
    Goekbuget, Nicola
    Zugmaier, Gerhard
    Degenhard, Evelyn
    Goebeler, Marie-Elisabeth
    Klinger, Matthias
    Neumann, Svenja A.
    Horst, Heinz A.
    Raff, Thorsten
    Viardot, Andreas
    Stelljes, Matthias
    Schaich, Markus
    Koehne-Volland, Rudolf
    Brueggemann, Monika
    Ottmann, Oliver G.
    Burmeister, Thomas
    Baeuerle, Patrick A.
    Nagorsen, Dirk
    Schmidt, Margit
    Einsele, Hermann
    Riethmueller, Gert
    Kneba, Michael
    Hoelzer, Dieter
    Kufer, Peter
    Bargou, Ralf C.
    [J]. BLOOD, 2012, 120 (26) : 5185 - 5187
12